arrow
Back
X

Xiubao Ren

tianjin medical university cancer institute and hospital

60H-index
454Paper Count
1.5WCitation Count
Published Papers 148
Publication Date
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial
err2025-12-04
err0
PREAI
errLin Wang; Xuezhi Hao; Yanrong Hao; Yanping Hu; Chun Chen; Bi Chen; Yunchao Huang; Aimin Zang; Yan Wang; Zhendong Chen; Wu Zhuang; Jinsheng Shi; Xiubao Ren; Ligong Nie; Guohua Yu; Feng Luo; Yimin Mao; Xiang Wang; Baolan Li; Yuansong Bai
errShare
errSave
A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinib
err2025-12-02
err0
errOAAI
errYuankai Shi; Dongqing Lv; Weineng Feng; Shuoyan Liu; Puyuan Xing; Yan Yu; Jun Yin; Xiubao Ren; Junqiang Zhang; Gaohua Han; Yongchang Zhang; Shundong Cang; Jun Chen; Enguo Chen; Lingxin Meng; Yong Zhang
errShare
errSave
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches
err2025-11-03
err0
errOAAI
errSharma, Amit; Sangiolo, Dario; Rosato, Antonio; Pu, Jingjing; Hou, Jian; Tettamanti, Sarah; Serafini, Marta; Fenix, Kevin Aaron; Introna, Martino; Rambaldi, Alessandro; Ren, Xiubao; Schmidt-Wolf, Ingo G. H.
errShare
errSave
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
err2025-09-01
err0
PREAI
errAiping Zhou; Pengfei Shen; Juan Li; Wang Qu; Zengjun Wang; Xiubao Ren; Yuan Li; Shusuan Jiang; Gang Li; Yu Zeng; Weijun Qin; Jin Wu; Peng Chen; Fangjian Zhou; Hongqian Guo; Zhigang Ji; Yongquan Wang; Zhisong He; Jitao Wu; Benkang Shi; Lian Liu; Xudong Yao; Lulin Ma; Ziling Liu; Xin Gou; Bin Fu; Shaogang Wang; Kui Jiang; Tie Chong; Xinhua Tu; Xu Zhang; Dexin Yu; Mulati Rexiati; Xueyi Xue; Jing Fei; Jianghou Wan; Liqun Jia; Yi He; Tongjian Cui; An-Qi Yang; Jun Guo; Xinan Sheng
errShare
errSave
errShare
errSave
CK2B Induces CD8+ T-Cell Exhaustion through HDAC8-Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti-PD-1 Therapy in Non-Small-Cell Lung Cancer
err2025-02-27
err1
errOAAI
errLiu, SC; Ma, SY; Liu, G; Hou, LJ; Guan, Y; Liu, L; Meng, Y; Yu, WW; Liu, T; Zhou, L; Yuan, ZY; Pang, SJ; Zhang, SY; Li, JY; Ren, XB; Sun, Q
errShare
errSave
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
err2024-10-28
err0
errOAAI
errPu, Jingjing; Liu, Ting; Sharma, Amit; Jiang, Liping; Wei, Feng; Ren, Xiubao; Schmidt-Wolf, Ingo G. H.; Hou, Jian
errShare
errSave
Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study
err2024-10-01
err0
errOAAI
errZhang, Wei-Hong; Li, Bing-Xue; Ma, Chen-Xi; Wang, Jian; Yang, Fan; Xiong, Yan-Juan; Li, Shu-Zhan; Zhang, Jia-Li; Du, Wei-Jiao; Hui, Zhen-Zhen; Shen, Meng; Zhou, Li; Li, Run-Mei; Tian, Xiao; Han, Ying; Ren, Bao-Zhu; Ichiki, Yoshinobu; Lee, Sang Chul; Zhang, Xin-Wei; Cao, Shui; Ren, Xiu-Bao; Liu, Liang
errShare
errSave
Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer (vol 15, 1302903, 2024)
err2024-06-14
err0
errOAAI
errFeng, Huijing; Zhang, Siyuan; Zhou, Qiuru; Han, Fei; Du, Gang; Wang, Lin; Yang, Xuena; Zhang, Xiying; Yu, Wenwen; Wei, Feng; Hao, Xishan; Ren, Xiubao; Zhao, Hua
errShare
errSave
errShare
errSave
Phosphoglycerate mutase 1 promotes breast cancer progression through inducing immunosuppressive M2 macrophages
err2024-05-15
err1
PREAI
errZhang, Dong; Wang, Min; Ma, Shiya; Liu, Min; Yu, Wenwen; Zhang, Xiying; Liu, Ting; Liu, Shaochuan; Ren, Xiubao; Sun, Qian
errShare
errSave
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma
err2024-05-01
err2
PREAI
errWei, Xiaoting; Zou, Zhengyun; Zhang, Weizhen; Fang, Meiyu; Zhang, Xiaoshi; Luo, Zhiguo; Chen, Jing; Huang, Gang; Zhang, Peng; Cheng, Ying; Liu, Jiwei; Liu, Jiyan; Zhang, Junping; Wu, Di; Chen, Yu; Ma, Xiaobiao; Pan, Hongming; Jiang, Renbing; Liu, Xinlan; Ren, Xiubao; Tian, Hongqi; Jia, Zhongwei; Guo, Jun; Si, Lu
errShare
errSave
A retrospective analysis of mature T- and NK-cell lymphomas
err2024-03-27
err1
errOAAI
errJia, Junlei; Wang, Xiaohui; Song, Zheng; Meng, Shen; Fei, Yue; Yu, Jingwei; Liu, Xia; Han, Xue; Li, Lanfang; Qiu, Lihua; Qian, Zhengzi; Zhou, Shiyong; Gong, Wenchen; Meng, Bin; Ren, Xiubao; Wang, Xianhuo; Zhang, Huilai
errShare
errSave
errShare
errSave
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm open-label, multicentre, phase 2 trial
err2024-03-01
err19
PREAI
errWang, Mengzhao; Fan, Yun; Sun, Meili; Wang, Yongsheng; Zhao, Yanqiu; Jin, Bo; Hu, Ying; Han, Zhigang; Song, Xia; Liu, Anwen; Tang, Kejing; Ding, Cuimin; Liang, Li; Wu, Lin; Gao, Junzhen; Wang, Jianghong; Cheng, Ying; Zhou, Jianying; He, Yong; Dong, Xiaorong; Yao, Yu; Yu, Yan; Wang, Huijie; Sun, Si; Huang, Jianan; Fang, Jian; Li, Wen; Wang, Lin; Ren, Xiubao; Zhou, Chengzhi; Hu, Yanping; Zhao, Dahai; Yang, Runxiang; Xu, Fei; Huang, Yijiang; Pan, Yueyin; Cui, Jiuwei; Xu, Yan; Yang, Zhenfan; Shi, Yuankai
errShare
errSave